ArticleFoods (Basel, Switzerland)2026
Remote-Controlled Microfluidic Platform for Real-Time Detection of Multiple Mycotoxins on Chip.
Article in Foods (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Liquid Metal-Enabled Soft Bioelectronics for Human Health Monitoring.Small (Weinheim an der Bergstrasse, Germany) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Food safety requires real-time monitoring of mycotoxins in food, as food products contaminated with these toxins poses major threat to human health. In this study, we proposed a remote-controlled microfluidic platform (RCMP) integrated with chemiluminescent/colorimetric detection system for rapid, cost-effective and real-monitoring of multiple mycotoxins in real samples based on the indirect competitive enzyme-linked immunosorbent assay (ic-ELISA). The RCMP enabled sensitive and automatic detection of deoxynivalenol (DON), zearalenone (ZEA), and fumonisin B1 (FB1) in the range of 4-128 ng/mL, 1-32 ng/mL, and 0.5-16 ng/mL, respectively. The limits of detection (LOD) were 2.881 ng/mL for DON, 0.702 ng/mL for ZEA, and 0.470 ng/mL for FB1. In further validation, satisfactory recoveries between 93.57% to 108.47% with the relative standard deviations (RSDs) of 6.92-11.39% were obtained in beer samples. Overall, RCMP provides an automatic, high-throughput and cost-effective method for detection of DON, ZEA, and FB1 and can be confidently applied for monitoring in beer samples.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.